Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

Clinical trial NCT00612040 · COMPLETED

Trial details

NCT number: NCT00612040
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Diabetes Mellitus, Type 1

Start date: 2008-01-01
Primary completion: 2008-06-01
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.